Spirax stock surges 15% on earnings beat and strong division growth

Spirax Group Plc (LON:SPX) shares jumped over 15% after the company reported first-half 2025 earnings that significantly beat expectations, with EBIT of £159 million against a £151 million consensus and group margins reaching 19.3%. This strong performance was driven by 3% organic sales growth and robust contributions from its Electric Thermal Solutions and Watson-Marlow divisions, the latter seeing biopharma orders rise over 10% and a book-to-bill ratio above 1. While full-year guidance remains unchanged, implying a more modest second half, analysts view these results as signaling the potential end of a downgrade cycle for Spirax, which could lead to a re-rating of its valuation multiples.

Analysis

Spirax Group Plc (LON:SPX) delivered a robust first-half 2025 performance, with shares surging over 15% after reported EBIT of £159 million surpassed consensus forecasts of £151 million. The beat was driven by stronger than expected group EBIT margins of 19.3% against an 18.6% estimate, alongside 3% organic sales growth. The Electric Thermal Solutions division was the primary growth engine, recording 10% organic sales growth fueled by heightened semiconductor demand and a significant data center contract. A pivotal development was observed in the Watson-Marlow division, where a book-to-bill ratio above 1 was achieved for the first time since 2021, signaling a potential acceleration in revenue growth to high single digits in the second half. This strength offset persistent weakness in the Steam Thermal Solutions unit, which was isolated to China and Korea and is expected to ease. Despite the strong first half, management maintained full-year guidance, implying a historically consistent 48%/52% H1/H2 EBIT split and a more moderate second half. The outlook for mid-single-digit operating profit growth is tempered by a notable 6% foreign exchange headwind. The key takeaway, echoed by Morgan Stanley, is that these results may mark an end to the company's earnings downgrade cycle, potentially restoring investor confidence and allowing for a valuation re-rating.

Key Decisions for Investors

• Investors should view the strong H1 results, particularly the inflection in the Watson-Marlow division's order book, as a potential sign that the operational turnaround is solidifying and the consensus downgrade cycle may be over.
• It is prudent to monitor the company's ability to navigate tougher second-half comparisons and a significant 6% foreign exchange headwind, as unchanged full-year guidance implies a more modest performance in H2.
• Focus on execution within the Electric Thermal Solutions division regarding its lower-margin backlog and any signs of recovery in the geographically challenged Steam Thermal Solutions unit, as these will be critical to meeting annual targets.